
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of First Trust NASDAQ-100 Equal Weighted Index Fund (NASDAQ:QQEW) through any online brokerage.
There are no as such competitors for First Trust NASDAQ-100 Equal Weighted Index Fund.
There is no analysis for First Trust NASDAQ-100 Equal Weighted Index Fund to provide a consensus price target.
The stock price for First Trust NASDAQ-100 Equal Weighted Index Fund (NASDAQ: QQEW) is $143.38 last updated December 12, 2025 at 4:05 PM EST.
There are no upcoming dividends for First Trust NASDAQ-100 Equal Weighted Index Fund.
First Trust NASDAQ-100 Equal Weighted Index Fund does not have any upcoming earnings scheduled.
There is no upcoming split for First Trust NASDAQ-100 Equal Weighted Index Fund.
| Sector | Technology |
| Category | High Performer-High Growth |
| Investment Style | Large Cap Growth |
| Fund Inception | Apr 19, 2006 |
| Managers | Stan Ueland David G. McGarel Daniel J. Lindquist Erik Russo Chris A. Peterson Jon C. Erickson Roger F. Testin |
| Definition | An equity fund portfolio full of stocks with both strong financial performance and superior growth potential |
| Symbol | Name | Share % |
|---|---|---|
| WBD | Warner Bros Discovery ... | 1.25% |
| INTC | Intel Corp. | 1.35% |
| AMD | Advanced Micro Devices... | 1.37% |
| AMAT | Applied Materials, Inc... | 1.30% |
| MU | Micron Technology, Inc... | 1.43% |
| LRCX | Lam Research Corp. Com... | 1.21% |
| ISRG | Intuitive Surgical Inc... | 1.30% |
| REGN | Regeneron Pharmaceutic... | 1.29% |
| BIIB | Biogen Inc | 1.26% |
| AZN | Astrazeneca Plc (Adr) | 1.19% |
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.